Ahmed M Aribi, M.D.

800-826-4673
Aribi-Ahmed
Hematologist
Clinical Expertise
Leukemia
Research Area
Hematology and Hematopoietic Cell Transplantation
Leukemia
Appointments
Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Clinical Teams
Hematology & Hematopoietic Cell Transplantation
Leukemia
Ahmed M. Aribi, M.D., joined the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope as an assistant professor and staff physician. Before coming to City of Hope, Aribi was an instructor within MD Anderson’s Department of Leukemia, Division of Cancer Medicine. Aribi completed fellowships at University of California, Los Angeles and MD Anderson, and before that was a resident and intern at Southern University in Springfield, Ill. He received his medical degree from Alfateh University School of Medicine in Libya. He is board certified in internal medicine and holds medical licenses in both California and Texas. 
Location
Education & Experience
Board Certifications

  • Board Certified in Internal Medicine

  • ECFMG Certified

  • State of California Medical License

  • State of Texas Medical License

Degrees

  • 1996 - Alfateh University School of Medicine, Libya, M.D.

Fellowship

  • 2008 -2011, Fellow, Department of Hematology, University of California Los Angeles, Los Angeles, CA

  • 2005 -2007, Fellow, Department of Hematology, Leukemia, M.D. Anderson Cancer Center, Houston, TX

  • 2000 - 2002, Postdoctoral Fellow in Neuro- Pharmacology, Department of Pharmacology Baylor College of Medicine, Houston, TX

Residency

  • 2003-2005 Southern Illinois University, Springfield, IL

Internship

  • 1997, Internal Medicine, Alfateh University affiliated hospitals, Libya

  • 2002 -2003, Department of Internal Medicine, Southern Illinois University, Springfield, IL

Professional Experience

  • 2011 - present, Assistant Professor, Hematology & Hematopoietic Cell Transplantation, City of Hope

  • 2007 - 2008, Instructor, Department of Leukemia, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Awards & Memberships
Memberships

  • American College of Physicians

  • American Medical Association

Publications
  • Ong, S. Y., Pak, S., Mei, M., Wang, Y., Popplewell, L., Baird, J. H., Herrera, A. F., Shouse, G., Nikolaenko, L., Zain, J., Godfrey, J., Htut, M., Aribi, A., Spielberger, R., Mansour, J., Forman, S. J., Palmer, J., & Budde, L. E. (2023). Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma. American journal of hematology, 10.1002/ajh.27069. Advance online publication. https://doi.org/10.1002/ajh.27069
  • Aribi, A., Salhotra, A., Afkhami, M., Munteanu, A., Ali, H., Aldoss, I., Otoukesh, S., Al Malki, M. M., Sandhu, K. S., Koller, P., Arslan, S., Stewart, F., Artz, A., Curtin, P., Ball, B., O'Hearn, J., Spielberger, R., Smith, E., Budde, E., Nakamura, R., … Pullarkat, V. (2023). WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens. Leukemia & lymphoma, 1–11. Advance online publication. https://doi.org/10.1080/10428194.2023.2241096
  • Amanam, I., Yao, J., Puing, A., Tsai, N. C., Samuels, D., Ngo, D., Ho, S., Ali, H., Aribi, A., Arslan, S., Artz, A., Htut, M., Koller, P., Salhotra, A., Sandhu, K., Nikolaenko, L., Pawlowska, A., Shouse, G., Stein, A., Marcucci, G., … Al Malki, M. M. (2023). Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer medicine, 12(10), 11248–11253. https://doi.org/10.1002/cam4.5832
  • Ngo, D., Chen, J., Tinajero, J., Aribi, A., Arslan, S., Marcucci, G., Nakamura, R., Al Malki, M. M., Forman, S. J., Dadwal, S., & Ali, H. (2023). The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study. Stem cell research & therapy, 14(1), 95. https://doi.org/10.1186/s13287-023-03326-3
  • La Rosa, C., Chiuppesi, F., Park, Y., Zhou, Q., Yang, D., Gendzekhadze, K., Ly, M., Li, J., Kaltcheva, T., Ortega Francisco, S., Gutierrez, M. A., Ali, H., Otoukesh, S., Amanam, I., Salhotra, A., Pullarkat, V. A., Aldoss, I., Rosenzweig, M., Aribi, A. M., Stein, A. S., … Diamond, D. J. (2023). Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study. Frontiers in immunology, 14, 1114131. https://doi.org/10.3389/fimmu.2023.1114131
  • Aldoss, I., Afkhami, M., Yang, D., Gu, Z., Mokhtari, S., Shahani, S., Pourhassan, H., Agrawal, V., Koller, P., Arslan, S., Tomasian, V., Al Malki, M. M., Artz, A., Salhotra, A., Ali, H., Aribi, A., Sandhu, K. S., Ball, B., Otoukesh, S., Amanam, I., … Pullarkat, V. (2023). High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. American journal of hematology, 98(6), 848–856. https://doi.org/10.1002/ajh.26908
  • Agrawal, V., Pourhassan, H., Tsai, N. C., Ngo, D., Koller, P., Malki, M. M. A., Salhotra, A., Ali, H., Aribi, A., Sandhu, K. S., Arslan, S., Ball, B., Otoukesh, S., Amanam, I., Artz, A., Singh, D., Becker, P. S., Stewart, F. M., Smith, E. P., Curtin, P., … Aldoss, I. (2023). Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab. Transplantation and cellular therapy, 29(5), 314–320. https://doi.org/10.1016/j.jtct.2023.01.017
  • Al Malki, M. M., Palmer, J., Tsai, N. C., Mokhtari, S., Hui, S., Tsai, W., Aldoss, I., Ali, H., Aribi, A., Cao, T., Mei, M., Sandhu, K. S., Siddiqi, T., Forman, S. J., Nakamura, R., Marcucci, G., Stein, A., Wong, J. Y. C., & Rosenthal, J. (2022). Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide. Blood advances, 6(14), 4098–4106. https://doi.org/10.1182/bloodadvances.2022007264
  • Aldoss, I., Yang, D., Tomasian, V., Mokhtari, S., Jackson, R., Gu, Z., Telatar, M., Yew, H., Al Malki, M. M., Salhotra, A., Khaled, S., Ali, H., Aribi, A., Sandhu, K. S., Mei, M., Arslan, S., Koller, P., Artz, A., Aoun, P., Gu, D., … Afkhami, M. (2022). Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL. Blood advances, 6(17), 4936–4948. https://doi.org/10.1182/bloodadvances.2022007597
Ratings & Reviews
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
Ratings
5.0
Provider explain in way you understand
4.9
Recommend this provider office
4.9
Provider listen carefully to you
4.9
Know important info medical history
4.9
Show respect for what you say
4.9
Spend enough time with you
4.9
Rate provider 0-10
Reviews
12/08/23
Everyone at City of Hope was just great - Verified patient
12/08/23
Dr.Aribi was wonderful - Verified patient
10/17/23
Good - Verified patient
10/17/23
Good - Verified patient
07/04/23
Good - Verified patient